Manchester, NH – Lyophilization Services of New England (LSNE), a New Hampshire based contract manufacturing organization is pleased to announce that the United States Food & Drug Administration (FDA) has concluded their most recent inspection of LSNE’s Medical Device facility located at 1 Sundial Avenue. This was a routine, general QSIT inspection and was the seventh successful inspection of this site. LSNE’s Sundial site is currently functioning as a multiproduct medical device manufacturing facility. The inspection was considered successful as there were no 483 observations cited by the FDA at the closeout.
Thomas McGrath, Vice President of Quality of LSNE stated, “We are very pleased with the result of the latest FDA inspection and the result of this inspection further demonstrates LSNE’s unwavering commitment to quality and patient safety.”